Disc Medicine, Inc. IRON
65.24
(1.20)
(1.81%)
as of 25 Sep
- Market cap
- $2.6B
- P/E
- 0.0×
Follow IRON
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 0.20 | 0.20 | 6.74 | 6.74 | 8.79 | 8.79 | 17.06 | 21.17 | 21.94 |
Net Debt/EBITDA |
— | (0.51) | (0.16) | 2.82 | 2.67 | 4.10 | 4.11 | 3.96 | 3.42 | 3.12 |
Debt/Assets |
0.00% | 260.13% | 119.62% | 1.79% | 5.85% | 0.67% | 0.00% | 0.00% | 5.70% | 3.61% |
Debt/Equity |
— | (0.99) | (0.46) | 0.02 | (0.08) | 0.01 | 0.00 | 0.00 | 0.06 | 0.04 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.80 | 0.80 | 0.77 | 0.77 | 0.90 | 0.90 | 0.96 | 0.86 | 0.85 |
Capex/Depreciation |
— | 0.00 | (0.07) | 0.00 | (2.12) | 0.00 | (1.70) | (0.89) | 0.10 | 0.11 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 186.80% | 186.80% | 83.59% | 56.02% | (83.32%) | (26.52%) | (29.30%) | (27.73%) | (35.86%) | |
| 0.00% | (981.78%) | (490.89%) | (71.42%) | (38.92%) | (32.01%) | (23.39%) | (26.90%) | (25.29%) | (32.55%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 209.24% | 209.24% | (45.64%) | (46.61%) | (26.38%) | (26.59%) | (22.19%) | (23.22%) | (27.61%) |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | — | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (21.64) | (21.65) | (31.35) | (31.44) | (40.65) | (40.81) | (3.30) | (3.42) | (5.14) |
Cash per Share |
— | 2.98 | 2.98 | 100.42 | 100.27 | 187.39 | 187.31 | 16.15 | 17.75 | 22.42 |
Shareholders Equity per Share |
— | (14.46) | (14.46) | 88.40 | (73.12) | 169.89 | 169.97 | 15.47 | 16.07 | 20.96 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (14.46) | (14.46) | 88.40 | (73.12) | 169.89 | 169.97 | 15.47 | 16.07 | 20.96 |
Free Cash Flow |
— | (32.71) | (32.73) | (27.53) | (27.60) | (42.25) | (42.40) | (73.55) | (94.43) | (181.33) |
Working Capital |
— | (19.81) | (19.81) | 77.06 | 77.06 | 175.91 | 175.91 | 344.22 | 470.30 | 767.26 |
Capital Expenditures |
— | (0.02) | (0.02) | (0.07) | (0.07) | (0.15) | (0.15) | (0.09) | (0.50) | (0.93) |
Net Current Asset Value |
— | (25.11) | (25.11) | 75.73 | (66.13) | 174.89 | 174.89 | 342.79 | 440.43 | 736.85 |
| Other line items | ||||||||||
Quick Ratio |
— | 0.18 | 0.18 | 6.57 | 6.56 | 8.63 | 8.62 | 16.81 | 21.01 | 21.59 |
Depreciation/Fixed assets |
— | 1.10 | 1.10 | 0.11 | 0.30 | 0.19 | 0.53 | 0.59 | (6.85) | (7.11) |
Cash ROIC |
— | (770.71%) | 445.55% | (17.48%) | (94.54%) | (11.76%) | (11.43%) | (10.44%) | (9.84%) | (11.64%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | — | 0.00 | — | 0.00 | — | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | — | 0.00 | — | 0.00 | — | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (21.64) | (21.64) | (31.35) | (31.36) | (40.65) | (40.67) | (3.29) | (3.40) | (5.11) |
Capex per Share |
— | 0.00 | (0.01) | 0.00 | (0.08) | 0.00 | (0.15) | 0.00 | (0.02) | (0.03) |
Average Payables |
— | 2.38 | 2.38 | 2.47 | 2.56 | 9.36 | 16.16 | 14.40 | 10.29 | 8.48 |
Average Assets |
0.00 | 4.16 | 8.32 | 50.37 | 92.41 | 146.31 | 200.21 | 284.10 | 432.38 | 651.83 |
Average Common Equity |
— | (21.86) | (21.86) | (43.03) | (64.20) | 56.20 | 176.60 | 260.86 | 394.35 | 591.71 |
Capex to Sales |
— | — | 0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates